Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high- risk HIV-negative women

被引:218
作者
Palefsky, JM
Holly, EA
Ralston, ML
Da Costa, M
Greenblatt, RM
机构
[1] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Stomatol, San Francisco, CA 94143 USA
[4] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
关键词
D O I
10.1086/318071
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Little is known about the epidemiology of anal human papillomavirus (HPV) infection in women. We studied 251 human immunodeficiency virus (HIV)-positive and 68 HIV-negative women for the presence of anal HPV by use of polymerase chain reaction (PCR) and hybrid capture. Medical and behavioral risk factors were evaluated; 76% of HIV-positive and 42% of HIV-negative women were found to have anal HPV DNA via analysis by PCR (relative risk [RR], 1.8; 95% confidence interval [CI], 1.3-2.5). Among 200 women for whom there were concurrent anal and cervical HPV data, anal HPV was more common than cervical HPV in both HIV-positive (79% vs. 53%) and HIV-negative women (43% vs. 24%). By multivariate analysis of HIV-positive women, CD4(+) cell counts less than or equal to 200 cells/mm(3), compared with counts >500 cells/mm(3) (RR, 1.4; 95% CI, 1.1-1.5), and cervical HPV infection (RR, 1.3; 95% CI, 1.1-1.4) were associated with anal HPV infection. Women >45 years old had reduced risk, compared with women <36 years old (RR, 0.80; 95% CI, 0.50-0.99), as did African American women (RR, 0.86; 95% CI, 0.72-1.0), compared with white women. Anal HPV infection is underrecognized in HIV-positive and high-risk HIV-negative women.
引用
收藏
页码:383 / 391
页数:9
相关论文
共 44 条
[31]   Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men - Prevalence and risk factors [J].
Palefsky, JM ;
Holly, EA ;
Ralston, ML ;
Arthur, SP ;
Jay, N ;
Berry, JM ;
DaCosta, MM ;
Botts, R ;
Darragh, TM .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1998, 17 (04) :320-326
[32]  
SILLMAN FH, 1987, OBSTET GYN CLIN N AM, V14, P537
[33]   Human papillomavirus infection in women infected with the human immunodeficiency virus [J].
Sun, XW ;
Kuhn, L ;
Ellerbrock, TV ;
Chiasson, MA ;
Bush, TJ ;
Wright, TC .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (19) :1343-1349
[34]   HUMAN PAPILLOMAVIRUS INFECTION IN HUMAN IMMUNODEFICIENCY VIRUS-SEROPOSITIVE WOMEN [J].
SUN, XW ;
ELLERBROCK, TV ;
LUNGU, O ;
CHIASSON, MA ;
BUSH, TJ ;
WRIGHT, TC .
OBSTETRICS AND GYNECOLOGY, 1995, 85 (05) :680-686
[35]   HIGH-RISK OF HUMAN PAPILLOMAVIRUS INFECTION AND CERVICAL SQUAMOUS INTRAEPITHELIAL LESIONS AMONG WOMEN WITH SYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
VERMUND, SH ;
KELLEY, KF ;
KLEIN, RS ;
FEINGOLD, AR ;
SCHREIBER, K ;
MUNK, G ;
BURK, RD .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 165 (02) :392-400
[36]   A LONGITUDINAL-STUDY OF HUMAN PAPILLOMAVIRUS DNA DETECTION IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1-SEROPOSITIVE AND TYPE-1-SERONEGATIVE WOMEN [J].
VERNON, SD ;
REEVES, WC ;
CLANCY, KA ;
LAGA, M ;
STLOUIS, M ;
GARY, HE ;
RYDER, RW ;
MANOKA, AT ;
ICENOGLE, JP .
JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (05) :1108-1112
[37]  
Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt
[38]  
12::AID-PATH431&gt
[39]  
3.0.CO
[40]  
2-F